Pharmacologically active peptide conjugates having a reduced...

Details Pharmacologically active peptide conjugates having a reduced... Pharmacologically active peptide conjugates having a reduced...

2004-12-07

2008-08-19

Lukton, David (Department: 1654)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

Synthesis of peptides

C530S333000, C530S324000, C530S325000, C530S326000, C530S327000

Reexamination Certificate

active

07414107

ABSTRACT:
The invention is directed to a pharmacologically active peptide conjugate having a reduced tendency towards enzymatic cleavage comprising a pharmacologically active peptide sequence (X) and a stabilizing peptide sequence (Z) of 4-20 amino acid residues covalently bound to X.

REFERENCES:
patent: 4018754 (1977-04-01), Inouye et al.
patent: 4081434 (1978-03-01), Li
patent: 4542124 (1985-09-01), Huffman
patent: 4707468 (1987-11-01), Yoshino et al.
patent: 4724229 (1988-02-01), Ali
patent: 4833125 (1989-05-01), Neer et al.
patent: 4847240 (1989-07-01), Ryser
patent: 5194586 (1993-03-01), Maeda et al.
patent: 5330971 (1994-07-01), Wells et al.
patent: 5376530 (1994-12-01), De The et al.
patent: 5545719 (1996-08-01), Shashoua
patent: 5646120 (1997-07-01), Smith et al.
patent: 5652122 (1997-07-01), Frankel
patent: 5688760 (1997-11-01), Kemp et al.
patent: 5723129 (1998-03-01), Potter et al.
patent: 5831001 (1998-11-01), Twist et al.
patent: 5968513 (1999-10-01), Gallow et al.
patent: 6126939 (2000-10-01), Eisenbach-Schwartz et al.
patent: 7176282 (2007-02-01), Holm et al.
patent: 2007/0004905 (2007-01-01), Holm et al.
patent: WO 91/19735 (1991-12-01), None
patent: WO 95/13085 (1995-05-01), None
patent: WO 97/24445 (1997-07-01), None
patent: WO 98/03192 (1998-01-01), None
patent: WO 98/11126 (1998-03-01), None
patent: WO 98/22577 (1998-05-01), None
patent: WO 98/28427 (1998-07-01), None
patent: WO 98/52614 (1998-11-01), None
Barany (Peptide & Protein Research 30, 705-739, 1987).
Sai et al., 1998, Amer. J. Physiol. 275:G514-G520.
Wakamiya et al., 1998, Bull. Chem. Soc. Jpn. 71:699-709.
Thomas et al., 1997, J. Pharm. Exp. Ther. 281:817-825.
Prokai, 1997, Exp. Opin. Ther. Patents 7(3):233-245.
Tamai et al., 1997, J. Pharm. Exp. Ther. 280:410-415.
Tamai et al., 1996, Adv. Drug Delivery Rev. 19:401-424.
Greene et al., 1996, J. Pharm.. Exp. Ther. 277:1366-1375.
Zhou et al., 1991, Intl. J. Pharm. 75:97-115.
Fawell et al., 1994, Proc. Natl. Acad. Sci. USA 91:664-668.
Duguay, 1995, J. Biol. Chem. 270:17566.
Steiner, 1992, J. Biol. Chem. 267-23435.
Docherty, 1987, Antimicrob Agents and Chemotherapy 31:1562.
Burger, 1951, J. Biol. Chem. 193:13.
I. V. Syskov, et al “Structural-Functional Organization Of ACTH: Synthesis And Properties Of Analogues Of The ACTH-(11-24)-Tetradeca- And ACTH-(1-24)- Tetracosapeptides Containing Hexa(Amino Acids) In Place Of The Natural ACTH 19-24 Sequence Of Amino Acids”, Translated fromBioorganicheskaya Khimiya, vol. 10, No. 5, pp. 618-625, May 1984.
Howells, “Proenkephalin biosynthesis in the rat,”NIDA Res. Monogr.70:43-65 1986.
Mascotti et al., “Thermodynamics of single-stranded RNA binding to oligolysines containing tryptophan,”Biochemistry. 31:8932-8946 1992.
Noguchi et al., “Dipeptides as inhibitors of the gelation of sickle hemoglobin,”Mol Pharmacol. 28:40-44 1985.
Rao et al. “Molecular cloning, sequence analysis and translation of proenkephalin mRNA from rat heart,”Regul. Pept. 40:397-408 1992.
Rosen et al., “Isolation and characterization of the rat proenkephalin gene,”J Biol Chem. 259:14309-14313 1984.
Shimohigashi et al., “Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide,”J Biol Chem.271:23642-23645 1996.
Tamiya et al., “Effect of synthetic Lys-Trp on adenosine triphosphatase activity of carp and rabbit myosin Bs,”Comp Biochem Physiol B. 75:23-25 1983.

Affiliated with

Also associated with

Rating

Pharmacologically active peptide conjugates having a reduced... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmacologically active peptide conjugates having a reduced..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmacologically active peptide conjugates having a reduced... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4007833